The LncRNA GATA3-AS1/miR-495-3p/CENPU Axis Predicts Poor Prognosis of Breast Cancer Via the PLK1 Signaling Pathway

The function of centromere protein U () gene in breast cancer has not been well understood. Therefore, we explored the expression profiles of gene in breast carcinoma to better understand the functions of this gene, as well as the relationship between expression and the prognosis of breast carcinoma patients. Our results indicate that was expressed at significantly higher levels in cancerous tissues than in normal tissues. Furthermore, expression correlated significantly with many clinicopathological characteristics of breast cancer. In addition, we discovered that high levels of expression predicted poor prognosis in patients with breast cancer. Functional investigation revealed that 180 genes exhibited co-expression with . Functional annotation indicated that 17 of these genes were involved in the PLK1 signaling pathway, with most of them (16/17) being expressed at significantly higher levels in malignant tissues compared with normal controls and correlating with a poor prognosis. Subsequently, we found that four miRNAs, namely hsa-miR-543, hsa-miR-495-3p, hsa-miR-485-3p, and hsa-miR-337-3p, could be regarded as potential expression regulators. Then, five lncRNAs were predicted to potentially bind to the four miRNAs. Combination of the results from expression, survival, correlation analysis and functional experiments analysis demonstrated the link between lncRNA GATA3-AS1/miR-495-3p/CENPU axis and prognosis of breast cancer. In conclusion, CENPU could be involved in cell cycle progression through PLK1 signaling pathway.